$RAPT

neutralCLOSED

AI Sentiment Score: 0/100|0 articles (7d)USD

$58.02+0.00 (+0.00%)

Open

$58.02

Day High

$58.02

Day Low

$57.98

Prev Close

$58.02

Volume

11.1M

Sentiment

0

0B · 0Be

Intraday Price Chart · 5-Min Candles

0 data points · Dashed line = EOD prediction

EOD Prediction

$58.02

+0.00 (+0.00%) vs now

AI Signal

— HOLD

Chart data unavailable (market may be closed)

Current: $58.02

EOD prediction is AI-generated from news sentiment only. Not financial advice.

Latest Analysis for $RAPT

bullishMar 15, 2026 · 10:00 PM

This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share

RAPT Therapeutics has been acquired for $58 per share, significantly benefiting a notable investor who built a considerable position worth $56 million last quarter. This acquisition highlights the potential of RAPT’s therapies in the oncology and inflammation sectors. The deal might attract further attention to the biopharmaceutical space as investors look for opportunities in similar companies. Stakeholders in RAPT will be pleased with the acquisition premium. Overall, this move signals confidence in RAPT’s drug pipeline and future commercialization prospects.

Impact Score8/10